168 related articles for article (PubMed ID: 2651534)
1. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity.
Gilbert DN; Wood CA; Kohlhepp SJ; Kohnen PW; Houghton DC; Finkbeiner HC; Lindsley J; Bennett WM
J Infect Dis; 1989 May; 159(5):945-53. PubMed ID: 2651534
[TBL] [Abstract][Full Text] [Related]
2. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Lane BP; Kaloyanides GJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494
[TBL] [Abstract][Full Text] [Related]
3. Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity.
Swan SK; Kohlhepp SJ; Kohnen PW; Gilbert DN; Bennett WM
Antimicrob Agents Chemother; 1991 Dec; 35(12):2591-5. PubMed ID: 1810193
[TBL] [Abstract][Full Text] [Related]
4. Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity.
Swan SK; Gilbert DN; Kohlhepp SJ; Leggett JE; Kohnen PW; Bennett WM
Antimicrob Agents Chemother; 1992 Nov; 36(11):2556-8. PubMed ID: 1489205
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic limits of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity.
Swan SK; Gilbert DN; Kohlhepp SJ; Kohnen PW; Bennett WM
Antimicrob Agents Chemother; 1993 Feb; 37(2):347-8. PubMed ID: 8452369
[TBL] [Abstract][Full Text] [Related]
7. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat.
Williams PD; Hottendorf GH
Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):317-20. PubMed ID: 3838817
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.
Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G
Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
Malis CD; Racusen LC; Solez K; Whelton A
J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion.
Zager RA
Am J Physiol; 1988 Apr; 254(4 Pt 2):F574-81. PubMed ID: 3354687
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of the constituents of the gentamicin complex.
Kohlhepp SJ; Loveless MO; Kohnen PW; Houghton DC; Bennett WM; Gilbert DN
J Infect Dis; 1984 Apr; 149(4):605-14. PubMed ID: 6725992
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on polyaspartic acid inhibition of gentamicin-induced generation of reactive oxygen species in guinea pig cochlea].
Guo Y; Jiang S; Yang W; Han D
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):267-70. PubMed ID: 12761993
[TBL] [Abstract][Full Text] [Related]
14. Transmission electron microscopy of urinary sediment in the assessment of aminoglycoside nephrotoxicity in the rat.
Mandal AK; Bennett WM
Nephron; 1988; 49(1):67-73. PubMed ID: 3380221
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of aminoglycosides in young and adult rats.
Provoost AP; Adejuyigbe O; Wolff ED
Pediatr Res; 1985 Nov; 19(11):1191-6. PubMed ID: 4069829
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
Williams PD; Hottendorf GH; Bennett DB
J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial gentamicin activity in the presence of exogenous protease inhibitor (Bowman-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats.
Smetana S; Khalef S; Bar-Khayim Y; Birk Y
Nephron; 1992; 61(1):68-72. PubMed ID: 1528344
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin and gram-negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure.
Zager RA; Prior RB
J Clin Invest; 1986 Jul; 78(1):196-204. PubMed ID: 3088042
[TBL] [Abstract][Full Text] [Related]
19. Polyaspartic acid inhibits gentamicin-induced perturbations of phospholipid metabolism.
Ramsammy L; Josepovitz C; Lane B; Kaloyanides GJ
Am J Physiol; 1990 Jun; 258(6 Pt 1):C1141-9. PubMed ID: 2360622
[TBL] [Abstract][Full Text] [Related]
20. Modification of experimental gentamicin nephrotoxicity by selective parathyroidectomy.
Bennett WM; Pulliam JP; Porter GA; Houghton DC
Am J Physiol; 1985 Dec; 249(6 Pt 2):F832-5. PubMed ID: 4073266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
